The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
Issam Ben Sahra(Inserm), Frédéric Bost(Inserm), Agnès Loubat(Inserm), Jean‐François Tanti(Inserm), Pascal Colosetti(Inserm), Sophie Giorgetti‐Peraldi(Inserm), Kathiane Laurent(Inserm), Y. Le Marchand‐Brustel(Inserm), Patrick Auberger(Inserm)
Cited by 852
Related Papers
The stomach is a source of leptin
|Nature|1998|1.2k
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
|Biochimie|2004|892
Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
|Endocrinology|2006|677
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
|Cancer Research|2011|620